- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04443621
Changes in the Perception of Personal Dignity Over the Course of Dementia (DIDEM)
Study Overview
Status
Intervention / Treatment
Detailed Description
A. Introduction to project, current state of art As the population ages, an increasing number of people will be diagnosed with dementia. At present, there are some 47 million people living with dementia worldwide. In Czech Republic, there are about 156,000 people suffering from dementia. Regional estimates of dementia prevalence in people aged 60 years and over now range from 4.6% in Central Europe to 8.7% in North Africa and the Middle East. It is estimated up to 131 million people with dementia will live in the world by 2050. Thus, there is a need of sensitive and specific cognitive assessment tools to detect cognitive impairment. It enables to provide timely intervention to delay the disease progression, prolong independence, and enhance the quality of life (QoL) and personal dignity of the individual with dementia.
Dementia is neurodegenerative disease characterized by progressive, irreversible and still incurable cognitive decline. People suffering from dementia retain their positive personality traits and character. However, as the illness progresses, symptoms such as memory loss, speech impairment, disorientation, difficulties with activities of daily living, and self-neglect are common. This leads to a significant interference with everyday social and work activities and has a negative impact on subjective perception of dignity. At present, the Mini Mental State Examination (MMSE) is used in the Czech Republic to diagnose dementia. Due to copyright issues with the MMSE (similar to the Montreal Cognitive Assessment [MoCA] questionnaire), there is a need for another valid tool to be free available in the country. Currently, the most frequently used tool in the world is the Addenbrooke's Cognitive Examination III (ACE-III), which is composed of five domains: orientation and attention; memory; fluency; language, and visuospatial function. The ACE-III-J is a sensitive and specific screening test to diagnose dementia, and it was better than the MMSE in accuracy for identifying dementia.
Dignity is described as an integral part of QoL. Similarly to QoL, dignity can also be understood as a multidimensional concept including: dignity of identity (self-worth/worthiness, integrity, trust); dignity as a human right (equality, freedom of choice); and dignity as expression of autonomy (independence, control. There are three main dimensions essential for constituting dignity: A historical dignity-dimension, acknowledging one's own life projects and history; an intrapersonal dignity-dimension, recognizing one's own human worth, and living according to individual values; and an interpersonal dignity-dimension, experiencing being part of a caring and confirming society.
Jacobson (2007) says that dignity exists in two complementary, yet disparate forms. It is understood as a dualistic concept incorporating absolute and relative dignity, objective and subjective dignity, and personal and social dignity. Personal dignity is a type of dignity that is subjectively perceived by an individual and is linked to a sense of worthiness. However, personal dignity is also contingent and contextual, and can be influenced both by an internal aspect, which is the worth and self-respect one ascribes to oneself, as well as by an external aspect, which is the worth and value ascribed to the individual by others.
Patients with a severe chronic disease (such as neurodegenerative) experience existential concerns related to changes in the self because of the disease, as well as the social consequences of the disease (e.g. embarrassment, role changes, loss of independence, and stigmatization), which can severely affect the sense of personal dignity.
Older adults with dementia (OAwD) are often experiencing an ongoing loss of personal dignity, value and security, and experiencing cognitive decline can be a threat towards self-respect and the sense of dignity. The key element of the dementia experience is the effort to preserve one's identity or sense of self and to preserve a meaningful life. Multiple personal losses and changes such as increased dependency, loss of autonomy and gradual loss of abilities or competencies can have a negative impact on the sense of self and the self-esteem of dementia sufferers. Thus, OAwD are in risk of personal dignity loss due to both impact of the disease on their identity and self-esteem, and indirectly through negative social interactions and experiences. Before entering the stage of severe dementia individuals are aware of the progressive decline in their abilities and actively try to cope with this decline. A sound sense of personal dignity is essential to the individual's overall experience of well-being and his/her QoL. Investigation of the factors that maintain and strengthen personal dignity needs to incorporate data collected from those afflicted. However, research how having dementia may impact personal dignity into person's subjective experience of mild to moderate dementia is only very recent.
Pilot data The proposed grant project builds on results of a previous project Trajectories of quality of life by the elderly in in early-stage dementia (No. 16-28628A). The findings of the project confirm that OAwD assess their QoL better when they have a greater sense of personal dignity. The validated Czech version of Patient Dignity Inventory (PDI-CZ) created and tested in our project No. 16-28628A will be used in the proposed project.
B. Project objectives, project timeline and description of methods and approaches To define the factors that pose a threat to personal dignity gives an opportunity for a deeper understanding of these issues. This can subsequently assist healthcare staff with choosing the optimum interventions supporting QoL amongst OAwD. The proposed project responds to a society-wide need to identify and solve psychosocial needs of an ageing population with emphasis on neurodegenerative diseases.
The objective of the project is to investigate the changes in the perception of personal dignity of OAwD. The opportunity to define risk factors threatening personal dignity over the course of dementia will contribute to a deeper understanding of patients' needs. This will help healthcare workers choose the optimum psychosocial interventions in accordance with Evidence Based Practice and thus protect dignity of OAwD as a major component of QoL. This may have a positive effect on the psycho-social dimension of QoL amongst OAwD and may lower the frequency and length of hospitalizations as well as save costs on healthcare and social services.
The main aim is to ascertain how the subjective perception of personal dignity in OAwD changes throughout the course of this disease (trajectory of personal dignity perception) and which factors affect it. Because different types of dementia might have different perceptions of personal dignity related to specific disturbances of cognitive domains, post-hoc subgroup analysis in different forms of dementia will be performed. For the assessment of cognition and diagnosis of dementia, the Addenbrooke's Cognitive Examination III (ACE-III), POBAV, and ALBA questionnaires will be used. For this reason, we need to create and validate a Czech version of the ACE-III as the first stage of the project.
In order to achieve the main aim, five sub-aims were identified which should make it possible to ascertain subjective perception of personal dignity and factors which affect in amongst OAwD:
- to create a Czech version of the ACE-III and to conduct a psychometric validation;
- to ascertain how the assessment of personal dignity changes over the course of 2 years;
- to identify sociodemographic and clinical factors perceived as a threat to dignity;
- post-hoc subgroup analysis of results among the different types of dementia;
- to define the differences in the perception of personal dignity among OAwD when using quantitative (PDI-CZ) and qualitative (in-depth interview) methods.
C. Methodology In order to reach the set aims, a mixed methods research design (quantitative survey first follow by qualitative interview) will be used to carry out a longitudinal, prospective study.
In the quantitative phase of the project using a battery of standardized questionnaires (3 stages). Research nurse gave QAwD the questionnaires and explained how to complete them. The questionnaires will be completed on project enrolment and then two more times at a 12-month interval.
In the qualitative phase of the research, individual in-depth interviews with OAwD on the topic of dignity (two interviews with each respondent at a 12-month interval) will be conducted, recorded, and transcribed with a subsequent interpretative phenomenological analysis. Two psychologists will be undertaking the interviews, in order to ensure that the interviews are conducted in the most sensitive manner. Informed consent will be secured before each interview. This will be carried out throughout project lifetime.
Questionnaire battery will be included: Addenbrooke's Cognitive Examination III (ACE-III), Amnesia Light and Brief Assessment (ALBA), POBAV, Patient Dignity Inventory (PDI-CZ), Bristol Activities of Daily Living Scale (BADLS-CZ), Geriatric Depression Scale (GDS), and a batch of socio-demographic and clinical characteristics (including age, sex, level of education, living arrangement, social life, frequency of social visits, telephone contact with relatives/friends, and the daytime spent alone, illnesses, medication, etc).
Sample The sample will consist of community-dwelling (i.e., living at home) older adults. They will be addressed together with their family caregivers in neurologic and geriatric outpatient offices.
Sample size:
First sample (quantitative research) will comprise of 500 respondents (310 OAwD for the longitudinal, three-stage study and 190 older adults for the validation study ACE-III).
Second sample (qualitative research) - after evaluating the 1st stage of the quantitative research, we will select 10 OAwD from the sample group with high level (average scale more than 3) and 10 OAwD who have low level of dignity to understand the different perspectives of perception of personal dignity. The exact number of respondents will depend on the thematic saturation in the course of interviewing.
Data from the quantitative research (validation study, and longitudinal study) will be gathered using a questionnaire from 310 OAwD (longitudinal study) and 190 older adults (half with dementia and half without dementia; validation study ACE-III) in neurologic and geriatric outpatients' departments in four regions of the Czech Republic. All data will be inserted into CASTOR database, from which they will be exported for statistical processing.
Data from the qualitative phase will be gathered using in-depth interviews with 20 OAwD. These respondents we will select after evaluation the 1st stage of the quantitative research (10 OAwD with high and 10 OAwD with low levels of dignity to understand the different perspectives in perception of personal dignity). An interpretative phenomenological analysis (IPA) will be applied. The IPA is an approach of a qualitative research, which is used to examine how people make sense of their major life experiences. The method is often used to study patients' lived experience. The data will be coded in NVivo 12 software for analysis. To assure reliability of the analysis, two researchers will code the interviews independently and they will confront their results for similarities and differences.
Study Type
Enrollment (Anticipated)
Contacts and Locations
Study Locations
-
-
-
Hradec Králové, Czechia
- University hospital Hradec Králové
-
Olomouc, Czechia
- University Hospital Olomouc
-
Olomouc, Czechia
- Palacky University
-
Ostrava, Czechia
- University Hospital Ostrava
-
Praha, Czechia
- Faculty Hospital Kralovske Vinohrady
-
-
Participation Criteria
Eligibility Criteria
Ages Eligible for Study
Accepts Healthy Volunteers
Genders Eligible for Study
Sampling Method
Study Population
Description
Inclusion Criteria:
- Group I.: age ≥60 years; lives at home; diagnosed with dementia (MMSE score 20 - 25 points), ability to consent to participate in the research; in contact with a family caregiver at least once a week.
- Group II: age ≥60 years; lives at home; MMSE score 26 - 30 points, ability to consent to participate in the research.
Exclusion Criteria:
- for both groups: severe psychotic disorder; severe cognitive impairment (severe hearing, visual or speech impairment), and terminal stage of caner or non-cancer disease.
Study Plan
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
---|---|
participants with early stage dementia
Subjects with diagnosed any type of dementia at an early phase (MMSE score 20 - 25 points) - for longitudinal study (three phasis).
|
Questionnaire battery for assessment of dignity, cognition, self-sufficiency, and depression.
Individual in-depth interviews with OAwD on the topic of dignity (two interviews with each respondent at a 12-month interval) .
|
participants without dementia
Subjects without dementia with MMSE score 26 - 30 points (for validation of ACE-III).
|
Questionnaire battery for assessment of dignity, cognition, self-sufficiency, and depression.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Addenbrooke's Cognitive Examination III (ACE-III)
Time Frame: 12 months
|
To create a Czech version of the ACE-III and to conduct a psychometric validation
|
12 months
|
Patient Dignity Inventory (PDI)
Time Frame: 24 months
|
To ascertain how the assessment of personal dignity changes over the course of two years
|
24 months
|
Factors affecting dignity
Time Frame: 24 months
|
To identify sociodemographic and clinical factors perceived as a threat to dignity (including age, sex, level of education, living arrangement, social life, frequency of social visits, telephone contact with relatives/friends, and the daytime spent alone, illnesses, depression, self-sufficiency etc).
|
24 months
|
Differences in the perception of personal dignity
Time Frame: 24 months
|
To define the differences in the perception of personal dignity among OAwD when using quantitative (PDI-CZ) and qualitative (in-depth interview) methods.
|
24 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Dignity among the different types of dementia
Time Frame: 24 months
|
Post-hoc subgroup analysis of results among the different types of dementia
|
24 months
|
Collaborators and Investigators
Sponsor
Collaborators
Investigators
- Principal Investigator: Helena Kisvetrova, PhD, Faculty of Health Sciences Palacky University Olomouc
Publications and helpful links
Study record dates
Study Major Dates
Study Start (ACTUAL)
Primary Completion (ANTICIPATED)
Study Completion (ANTICIPATED)
Study Registration Dates
First Submitted
First Submitted That Met QC Criteria
First Posted (ACTUAL)
Study Record Updates
Last Update Posted (ACTUAL)
Last Update Submitted That Met QC Criteria
Last Verified
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- NU20-07-00100
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Dementia
-
University of North Carolina, Chapel HillNational Institute on Aging (NIA)CompletedAlzheimer Dementia | Dementia Alzheimers | CaregiverUnited States
-
Temple UniversityRecruitingDementia | Mild Cognitive Impairment | Dementia, Vascular | Dementia, Mixed | Dementia Alzheimers | Mild Dementia | Dementia of Alzheimer Type | Dementia, MildUnited States
-
Hebrew SeniorLifeRecruitingAging | Alzheimer Dementia | Presenile Alzheimer DementiaUnited States
-
Temple UniversityRecruitingDementia | Alzheimer Disease | Mild Cognitive Impairment | Dementia, Vascular | Dementia, Mixed | Dementia Alzheimers | Mild Dementia | Dementia of Alzheimer Type | Dementia, MildUnited States
-
Cognito Therapeutics, Inc.Enrolling by invitationExtension to a Pivotal Study of Sensory Stimulation in Alzheimer's Disease (OLE Hope Study, CA-0015)Cognitive Impairment | Alzheimer Disease | Mild Cognitive Impairment | Dementia Alzheimers | Dementia of Alzheimer Type | AD | Dementia, Mild | Dementia ModerateUnited States
-
National Tainan Junior College of NursingCompletedCognitive Impairment | Dementia, Mild | Dementia ModerateTaiwan
-
Karen RobertoNational Institute on Aging (NIA)RecruitingDementia | Dementia Alzheimers | Neuro-Degenerative Disease | Dementia of Alzheimer Type | Dementia SevereUnited States
-
University College, LondonNot yet recruitingDementia | Dementia, Vascular | Dementia, Mixed | Dementia With Lewy Bodies | Dementia of Alzheimer Type | Dementia Moderate | Dementia Severe | Dementia Frontal | DEM
-
University College, LondonThe University of Hong KongUnknownDementia | Dementia, Vascular | Dementia, Mixed | Dementia With Lewy Bodies | Dementia of Alzheimer Type | Dementia Moderate | Dementia Severe | Dementia Frontal
-
Karolinska InstitutetRegion Stockholm; KTH Royal Institute of TechnologyActive, not recruitingAlzheimer Dementia | Dementia DisordersSweden
Clinical Trials on questionnaire
-
H. Lee Moffitt Cancer Center and Research InstituteSan Diego State University; University of Minnesota; University of ArizonaCompletedAnxiety | Psychological StressUnited States
-
Centre Hospitalier Universitaire de NiceCompletedGeneral Population | TDAH | Children Aged 5 to 18 YearsFrance
-
Minneapolis Veterans Affairs Medical CenterUnited States Department of DefenseCompletedLower Limb Amputation Below Knee (Injury) | Lower Limb Amputation Above Knee (Injury)United States
-
NSABP Foundation IncNational Cancer Institute (NCI)Completed
-
Imperial College LondonRoyal Marsden NHS Foundation Trust; University College London Hospitals; The... and other collaboratorsCompleted
-
Stanford UniversityRecruitingAstigmatism | Nearsightedness | FarsightednessUnited States
-
University of LiegeCompletedCritical Illness | Covid19 | Psychological Stress | FamilyBelgium
-
Imperial College Healthcare NHS TrustNot yet recruitingCervical Myelopathy
-
Rabin Medical CenterCompleted
-
National Taiwan University HospitalNational Taiwan UniversityUnknownComputerized Physician Order EntryTaiwan